ERBB2 and breast cancer: We conducted a retrospective cohort study to investigate treatment patterns and outcomes of women diagnosed with metastatic or recurrent BC between 2010 and 2019, stratified by HER2 status (IHC0/low) and de novo/recurrent status in a real-world Canadian setting.